The stock's fall snapped a five-day winning streak.

This was the stock's fifth consecutive day of gains.

Hypertension Diagnostics (OTCMKTS:HDII – Get Free Report) and Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will ...

Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report)‘s stock had its “market outperform” rating restated by JMP Securities ...

H.C. Wainwright lowered the firm’s price target on Inovio (INO) to $3 from $5 and keeps a Neutral rating on the shares after the company ...

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

JMP Securities analyst Roy Buchanan reiterated a Buy rating on Inovio Pharmaceuticals (INO – Research Report) today and set a price target of ...

Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company with a market capitalization of $51.55 million focused on developing DNA-based immunotherapies for infectious diseases and cancer ...

Inovio Pharmaceuticals shares are trading higher by 17.9% Tuesday afternoon. Vaccine stocks are rising amid growing concerns about respiratory illnesses. Inovio Pharmaceuticals Inc INO shares are ...

Inovio Pharmaceuticals, Inc. (NASDAQ:INO), a biotechnology company with a market capitalization of $51.55 million focused on developing DNA-based immunotherapies for infectious diseases and cancer, ...

Shares of Inovio Pharmaceuticals pulled back by 5.3% during Wednesday’s session. The decline may be attributed to profit-taking, as investors assess renewed focus on respiratory illnesses.